4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-386436
Chief Executive Officer sold 8,210 shares at an average $45.61 ($374,498)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ceesay Abraham Chief Executive Officer | 2026-09-08 | Sale 10b5-1 | −7,141 | $45.56 | $325,308 | 460,046 | D |
| Ceesay Abraham Chief Executive Officer | 2026-09-08 | Sale 10b5-1 | −1,069 | $46.01 | $49,190 | 458,977 | D |
| Open-market sales · 8,210 sh · avg $45.61 · $374,498 | |||||||
Loading xslF345X06/ownership.xml…